Day One Biopharmaceuticals (DAWN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist

14.160
-0.130-0.91%

Close Sep 27 16:00 ET

14.790
+0.630+4.45%

Post 18:34 ET

1.41BMarket Cap-7298P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Watching Shares Of Day One Biopharmaceuticals; Martin Shkreli Post On X, "The Stock $DAWN Is a Good Long Idea. Probably Doubles."
BenzingaSep 20 13:20 ET
Day One Biopharmaceuticals Insider Sold Shares Worth $426,675, According to a Recent SEC Filing
MT NewswiresSep 12 16:52 ET
TD Cowen Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating
Moomoo NewsSep 9 07:31 ET · Ratings
TD Cowen Keeps Their Buy Rating on Day One Biopharmaceuticals (DAWN)
TipRanksSep 9 07:16 ET · Ratings
Express News | Day One Biopharmaceuticals Inc Files for Offering of up to 12.1 Mln Shares by the Selling Stockholders - SEC Filing
ReutersAug 28 16:08 ET
A Great Week That Adds to Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) One-year Returns, Institutional Investors Who Own 56% Must Be Happy
Yahoo FinanceAug 16 07:39 ET

Comments

IDKWTFIMDOING

Jul 26 02:43

$Day One Biopharmaceuticals (DAWN.US)$
https://www.tipranks.com/news/blurbs/strong-buy-rating-for-day-one-biopharmaceuticals-amid-strategic-partnership-and-promising-financial-health?futusource=news_stock_stockpagenews&ns_stock_id=80620831336770&src=2&utm_medium=referral&utm_source=moomoo.com&client_hour_clock=24&clientlang=2

Trytosaveabit

Jul 25 15:47

$Day One Biopharmaceuticals (DAWN.US)$ Ipsen And Day One Enter Ex-U.S. Licensing Deal For Pediatric Brain Cancer Drug Tovorafenib
Benzinga· 01:54
Ipsen secures ex-U.S. regulatory and commercial rights to tovorafenib for most common childhood brain tumor, pediatric low-grade glioma (pLGG), and any future indications
OJEMDA (tovorafenib) is the first FDA-approved treatment for relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or V600 mutation, following the pivotal Phase II tria...

MARKET-TEST-DUMMY

Jun 20 04:39

turn around

$Day One Biopharmaceuticals (DAWN.US)$ we gonna see retraisement back to 18?

Trytosaveabit

Jun 12 19:34

Update

$XOMA Corp (XOMA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher